Outlook Therapeutics Inc (OTLK)
7.54
+0.14
(+1.89%)
USD |
NASDAQ |
May 15, 15:28
Outlook Therapeutics Total Liabilities (Quarterly): 46.03M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.03M |
| September 30, 2023 | 46.74M |
| June 30, 2023 | 49.95M |
| March 31, 2023 | 43.54M |
| December 31, 2022 | 46.93M |
| September 30, 2022 | 19.79M |
| June 30, 2022 | 18.51M |
| March 31, 2022 | 31.72M |
| December 31, 2021 | 29.85M |
| September 30, 2021 | 18.20M |
| June 30, 2021 | 20.13M |
| March 31, 2021 | 24.46M |
| December 31, 2020 | 22.99M |
| September 30, 2020 | 16.91M |
| June 30, 2020 | 19.28M |
| March 31, 2020 | 33.69M |
| December 31, 2019 | 35.83M |
| Date | Value |
|---|---|
| September 30, 2019 | 27.90M |
| June 30, 2019 | 34.57M |
| March 31, 2019 | 40.22M |
| December 31, 2018 | 40.18M |
| September 30, 2018 | 43.09M |
| June 30, 2018 | 43.35M |
| March 31, 2018 | 43.06M |
| December 31, 2017 | 40.17M |
| September 30, 2017 | 51.46M |
| June 30, 2017 | 46.07M |
| March 31, 2017 | 44.31M |
| December 31, 2016 | 42.28M |
| September 30, 2016 | 30.58M |
| June 30, 2016 | 31.43M |
| March 31, 2016 | 45.30M |
| December 31, 2015 | 45.82M |
| September 30, 2015 | 64.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.91M
Minimum
Sep 2020
49.95M
Maximum
Jun 2023
30.90M
Average
29.85M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Cutera Inc | 504.56M |
| Actinium Pharmaceuticals Inc | 44.50M |
| GT Biopharma Inc | 6.633M |
| Karyopharm Therapeutics Inc | 373.41M |
| Marinus Pharmaceuticals Inc | 153.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.68M |
| Shareholders Equity (Quarterly) | -24.34M |